Responses
Rheumatology
Protocol
Feasibility randomised multicentre, double-blind, double-dummy controlled trial of anakinra, an interleukin-1 receptor antagonist versus intramuscular methylprednisolone for acute gout attacks in patients with chronic kidney disease (ASGARD): protocol study
Compose a Response to This Article
Other responses
No responses have been published for this article.